Clinical Trial Update: Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay

View source ↗

Summary

Clinical performance evaluation of the NeuMoDx FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 assay completed, assessing detection of influenza A and B, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Snippet

Sponsor: QIAGEN Gaithersburg, Inc | Conditions: Respiratory Disease | Status: COMPLETED